Advance Agrolife

Why is Advance Agrolife Ltd falling/rising?

As of 08-Aug, Advance Agrolife Ltd's stock is experiencing a decline of 1.89% over the last two days, totaling a 4.6% drop, but strong fundamentals and increased investor interest indicate potential for long-term recovery.

As of 08-Aug, Advance Agrolife Ltd's stock price is currently falling, with a change of -2.45, representing a decline of 1.89%. This downward movement is part of a broader trend, as the stock has been losing for the last two days, resulting in a total decline of 4.6% during this period. Additionally, today's performance indicates that the stock has underperformed its sector by 1.1%. <BR><BR>Despite these short-term declines, there are several positive indicators for the company. For instance, it is net-debt free and reported a significant growth in net profit of 202.28% in its latest results. The company has also achieved its highest operating profit to interest ratio at 17.27 times and recorded its highest net sales at Rs 330.40 crore. Furthermore, the stock is trading above its moving averages across various time frames, suggesting a generally positive long-term trend.<BR><BR>Investor participation has also increased, with a notable rise in delivery volume by 279.84% against the 5-day average, indicating growing interest in the stock. Institutional investors have increased their stake by 1.4% over the previous quarter, which could provide additional support for the stock in the future.<BR><BR>In summary, while Advance Agrolife Ltd is currently experiencing a decline in stock price, driven by recent performance and market conditions, there are strong fundamentals and increasing investor interest that suggest potential for recovery in the longer term.

Which are the latest news on Advance Agrolife?

Should I buy, sell or hold Advance Agrolife Ltd?

When is the next results date for Advance Agrolife Ltd?

The next results date for Advance Agrolife Ltd is August 6, 2026.

The next results date for Advance Agrolife Ltd is scheduled for August 6, 2026.

What does Advance Agrolife do?

Advance Agrolife Ltd operates in the pesticides and agrochemicals sector, reporting net sales of 124 Cr and a net profit of 7 Cr for March 2026, with a market cap of INR 651 Cr. Key metrics include a P/E ratio of 18.00 and a debt-equity ratio of 0.07.

Overview: <BR>Advance Agrolife Ltd operates in the pesticides and agrochemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The incorporation year is not provided, and there are no status changes mentioned. The latest quarter for which sales and profit are reported is March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 124 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 7 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 651 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 18.00 <BR>Industry P/E: 29 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 11.38% <BR>Price-to-Book: 2.06 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

How big is Advance Agrolife?

As of 10th June, Advance Agrolife Ltd has a market capitalization of 651.00 Cr, with recent net sales of 637.78 Cr and a net profit of 35.29 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Advance Agrolife Ltd has a market capitalization of 651.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 637.78 Cr, while the sum of Net Profit for the same period is 35.29 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 100.87 Cr, and Total Assets amount to 350.71 Cr.

Who are the peers of the Advance Agrolife?

Advance Agrolife's peers include Astec Lifescienc, Punjab Chemicals, Meghmani Organi., Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, and Crop Life Scienc. Key insights show Dharmaj Crop has excellent management and capital structure, while Bhaskar Agrochem leads in 1-year returns at 28.03%, and Meghmani Organi. has the lowest at -49.01%.

Peers: The peers of Advance Agrolife are Astec Lifescienc, Punjab Chemicals, Meghmani Organi., Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dharmaj Crop and Bhaskar Agrochem, while Average management risk is found at Punjab Chemicals, Meghmani Organi., Heranba Inds, and Crop Life Scienc. Below Average management risk is noted at Astec Lifescienc, Shivalik Rasayan, and Best Agrolife. Growth is rated as Good for Dharmaj Crop, Average for Punjab Chemicals, Bhaskar Agrochem, and the rest, while Below Average growth is seen at Astec Lifescienc, Meghmani Organi., Heranba Inds, Best Agrolife, Shivalik Rasayan, and Crop Life Scienc. Capital Structure is Excellent for Dharmaj Crop and Shivalik Rasayan, Good for Punjab Chemicals, Average for Heranba Inds, Best Agrolife, and the rest, while Below Average is noted at Astec Lifescienc, Meghmani Organi., and Bhaskar Agrochem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bhaskar Agrochem at 28.03%, while Meghmani Organi. has the lowest at -49.01%. Advance Agrolife's 1-year return is not available for comparison. Additionally, several peers, including Heranba Inds, Best Agrolife, Shivalik Rasayan, and Meghmani Organi., have negative six-month returns.

Are Advance Agrolife Ltd latest results good or bad?

Advance Agrolife Ltd's latest results show strong profit growth, with a 421.68% increase in net profit for Q4 FY26, but revenue has declined sequentially, raising concerns about sustainability. Additionally, cash flow issues and reduced institutional investor participation suggest caution regarding the company's long-term prospects.

Advance Agrolife Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q4 FY26, reaching ₹7.46 crores, which is up 421.68% year-on-year and 147.90% quarter-on-quarter. This indicates strong profitability improvement and operational efficiency, as reflected in the expansion of the PAT margin to 6.02%, up from 1.59% a year prior.<BR><BR>However, the revenue figures tell a different story. The company recorded revenue of ₹123.88 crores, which represents a robust year-on-year growth of 37.90%. Yet, it also experienced a sequential decline of 6.60% from the previous quarter, highlighting volatility in revenue generation. This inconsistency raises concerns about the sustainability of the recent profit growth.<BR><BR>Additionally, while operating margins improved to 10.80%, the company faces challenges related to cash flow generation, with operating cash flow dropping significantly to ₹5.00 crores from ₹14.00 crores in the prior year. Furthermore, there has been a notable decline in institutional investor participation, which could signal caution among sophisticated investors regarding the company's long-term prospects.<BR><BR>In summary, while the profit growth is commendable, the underlying issues with revenue consistency and cash flow generation, along with declining institutional confidence, suggest that the overall results may not be as favorable as the profit figures alone would indicate. Investors should consider these factors when evaluating the company's performance.